Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Charney Laurence N | Nov 11, 2024 | Sell | 25,000 | $30.195 | $750,000 |
| Lonial Sagar | Nov 11, 2024 | Sell | 5,000 | $30.44 | $150,000 |
| Echelard Yann | Nov 5, 2024 | Sell | 20,000 | $24.48 | $490,000 |
| Lonial Sagar | Jun 20, 2024 | Sell | 16,348 | $16.87 | $280,000 |
| Lonial Sagar | Jun 17, 2024 | Sell | 9,585 | $16.39 | $160,000 |
| Lonial Sagar | Mar 13, 2024 | Sell | 5,000 | $15.935 | $80,000 |
| Charney Laurence N | Mar 12, 2024 | Sell | 22,000 | $15.97 | $350,000 |
| Charney Laurence N | Jan 5, 2024 | Sell | 17,500 | $19.03 | $330,000 |
| Power Sean A | Jan 3, 2024 | Sell | 47,867 | $16.91 | $810,000 |
| WEISS MICHAEL S | Aug 11, 2023 | Buy | 100,000 | $10.13 | $1M |
| Lonial Sagar | Jun 23, 2023 | Sell | 34,854 | $23.37 | $810,000 |
| Power Sean A | Jun 2, 2023 | Sell | 73,647 | $26.7 | $2M |
| Echelard Yann | Jan 6, 2023 | Buy | 9,000 | $10.64 | $96,000 |
| Charney Laurence N | Jan 4, 2023 | Sell | 30,000 | $11.1 | $330,000 |
What's the latest insider transaction for TG Therapeutics?
The most recent insider transaction for TG Therapeutics was conducted by Charney Laurence N, who sold 25,000 shares on November 11, 2024 at a price of $30.20 per share.
Which insider bought the most TGTX stock over the last two years?
WEISS MICHAEL S has bought the most TGTX stock in the last 2 years, with a total value of $1M.
Which insider has sold the most TGTX stock over the last two years?
Power Sean A has sold the most TGTX stock in the last 2 years, with a total value of $2.8M.
What is the total value of insider transactions for TG Therapeutics (TGTX) in the last 2 years?
The total value of insider transactions for TG Therapeutics in the last 2 years is negative, amounting to -$5.4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on TG Therapeutics' market confidence?
Over the last 2 years, insider transactions for TG Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
